Oradores

Rita Prazeres

Rita Prazeres

EU Head of Regulatory Affairs & Technical Director, Clever Leaves

Rita Prazeres has a degree in Pharmaceutical Sciences from the Faculty of Pharmacy of Lisbon’s University, Portugal. Regulatory Affairs Specialist by the Portuguese Pharmaceutical Order (College of the Speciality of Regulatory Affairs) and Post-graduated in GMP for Medicinal Cannabis from the Faculty of Pharmacy of Lisbon’s University & Military Laboratory.
 
Rita has more than 20y in Pharmaceutical Industry, having experienced many different company ‘environments due to several Mergers & Acquisitions. More than 14y as Director of Regulatory Affairs, Market Access and Pharmacovigilance of Actavis & Aurobindo Pharma Groups, responsible for Registration of medicinal products, Price & Reimbursement, Pharmacovigilance, Portfolio management and Intellectual Property Management.
 
In 2019, Rita embraced a new challenge in the Medicinal Cannabis as EU Head of Regulatory Affairs & Technical Director at Clever Leaves Portugal. Responsible for the licensing activities of the company in Portugal, overseeing Quality Compliance (Quality Assurance & Quality Control) and Cannabis Regulatory framework in Europe.

Olga Morales

Olga Melero Morales

Sales Manager Spain at Ionisos Ibérica

Olga Melero Morales, has a university degree in Chemistry from UAM (Universidad Autónoma de Madrid) and a master in Marketing and Sales from ESIC Business and Marketing School. She’s also a Radioactive Facility Supervisor issued by CNS (Consejo de Seguridad Nacional).
 
Olga has been working for Ionisos Ibérica for the last 20 years in several departments, first as validations and quality control responsible, later as customer support and finally as Sales and business development manager of Ionisos in Spain.

Marta Velez

Marta Rodríguez Vélez

Associate Consultant at Azierta

Marta Rodríguez Vélez is a Biologist, Master’s Degree in Pharmaceutical Industry and Master’s Degree in Business Administration.
 
During her 20 years of professional career, she has always been engaged with the pharmaceutical industry, being involved in research projects, clinical trials and, during her last 17 years, as consultant for pharmaceutical companies, with a high expertise in Regulatory Affairs, Pharmacovigilance and Quality Assurance in the industrial area.
 
During the last 5 years she has led several Medical Cannabis projects globally, acting as a consultant and project manager, helping companies to understand the applicable regulation and to align their business strategy with the regulatory strategy. She was Director of the MedCannHub by Azierta, from which she managed projects in various areas related to the medical cannabis industry in Europe and Latin America. She’s now Associate Consultant for Azierta.
 
She is member of the board in the Spanish Association of Industry Pharmacist (AEFI), speaker in courses and conferences and associate professor in Pharma Business Schools.
 
Marta’s role is to advise Life Science companies to guarantee their compliance with existing regulations and to lead the continuous improvement of their teams and systems.

Philipe Henry

Philippe Henry

CSO Leysin Scientific and Cannabis Quality Assurance (CQA) inc.

One of Canada’s foremost cannabis geneticists, Philippe Henry a former professor of evolutionary genetics, his broad interests in biodiversity and conservation has led to numerous scientific initiatives.
 
An expert in predictive chemotyping, he is interested in bringing transparency, consistency and traceability to the cannabis and psychedelic space.
 
Henry is the former CTO at Digipath Labs Inc. (Las Vegas, NV), CSO at VSSL Enterprises Ltd. (West Kelowna, BC), VP of R&D at the Flowr Corporation (Lake Country, BC), he is the founder of Shaman Distribution Inc. (Vancouver, BC). and Akitig Mushrooms Inc. (Armstrong, BC) as well as the Swiss entity Ch4 Supply Sarl. (Leysin, CH).

Philippe also serves as a scientific advisor to Amma Ventures LLC (New York City, NY and Medellin, CO), The Emerald Flower Farm Inc. (Kelowna, BC), Island Genetics Inc. (Ladysmith, BC), and Lighthouse Genomics Inc. (Vancouver, BC).

Aldo Vidinha

Aldo Vidinha

CEO of Stepwise Pharma & Engineering

Aldo Vidinha, CEO and Founder of Stepwise – Pharma & Engineering, internationally experienced leader with over 14 years’ experience in pharmaceutical industry in areas such as Engineering, Validation & Qualification, GMP Compliance, Quality Assurance and Manufacturing.
 
Co-founder and former COO of Holigen, a Portuguese GMP Medicinal Cannabis licensed producer.
 
Project lead for CapEx projects up to €18 million in major international pharmaceutical players.
 
Expert in Medicinal Cannabis industry, that has led and delivered a fully licensed Medicinal Cannabis company and facilities.
 
Highly driven and motivated leader experienced in business strategic thinking, building High Performance Teams and business consulting (executive and governance levels).

Sara Figueiredo

Sara Figueiredo

Responsible of the Introduction of New Products & Microbiological Control Department at LEF

Sara Figueiredo has a degree in Pharmaceutical Sciences from the Faculty of Pharmacy, University of Lisbon. She is currently developing a doctoral project in the scope of three-dimensional printing of medicines at FFUL, in collaboration with LEF – Infosaúde and Research Centre of Egas Moniz.

She started her professional activity as laboratory technician at Quality Control & Stability department in LEF – Infosaúde. During the period of 2018 to 2021, Sara Figueiredo assumed the supervisor role in the same department.

Nowadays and since 2021 she is responsible of the Introduction of New Products & Microbiological Control department at LEF, in which all analytical activities in the scope of Medical Cannabis are carried out.

Additionally, she is author of scientific communications and publications in congresses and scientific journals. Her academic experience also includes the role of teacher in technical-scientific courses from 2016 to the present.

Nuno Santos

Nuno Santos

Pharma Business Unit Manager at Stepwise Pharma & Engineering

Nuno Rebelo dos Santos is Pharma Business Unit Manager at STEPWISE – PHARMA & ENGINEERING.

Chemist with a post-graduation in business administration has over of 15 years of experience in multinational chemical and pharmaceutical industries, from API development to drug product manufacturing.

Quality Assurance professional with vast experience in the shopfloor, production, auditing, inspection and in leading the approval of pharmaceutical units by national and international health authorities.

Project Manager for Drug Product activities with world’s top 5 Pharmaceutical player.

Experience in Medicinal Cannabis, API, oral and parenteral Drug Product industries.

Fabio Teles

Fábio Teles

Quality Consultant Manager at LEF

Graduated in Pharmaceutical Sciences at Coimbra’s Faculty of Pharmacy, Fábio Teles has been doing his career on Pharmaceutical Industry, more specifically on Quality Assurance field.

After completing his master’s degree, Fábio started his work life in Labesfal – Fresenius Kabi Portugal, in Quality Assurance Unit – Personnel Qualification and then moved to Tecnimede to integrate Group Quality Unit.

Now, Fábio is the Quality Consultant Manager of LEF, where support medicinal cannabis players to get their authorizations, implement their quality systems and be in compliance with all legislation and good practices, in order to help them on achieving their goals.

Catarina Serra

Catarina Serra

Quality Consultant at LEF

It was at LEF that Catarina Serra began her professional pharmaceutical career, three years ago.

Graduated in Pharmaceutical Sciences at Lisbon’s Faculty of Pharmacy, with a certification in Toxicology for Pharmaceutical and Regulatory by the American College of Toxicology (ACT), Catarina has also a Biomedical Sciences bachelor from Coimbra Health School, having always wanted to work in health sciences.

Nowadays, Catarina integrates LEF’s consultancy team, being responsible for providing a toxicologically driven viewpoint in the elaboration of risk assessments and in supporting the implementation of quality systems for the pharmaceutical industry and more specifically, cannabis-based companies.

André Neves

André Neves

Qualified Person of Tilray Portugal

André Neves, Qualified Person of Tilray Portugal, has a degree in Pharmaceutical Sciences and a post-graduation in Pharmaceutical Technology from the Faculty of Pharmacy of Coimbra University, and specialist title in Pharmaceutical Industry by the Portuguese Pharmaceutical Order (College of the Speciality of Pharmaceutical Industry).

André developed his professional career in the pharmaceutical industry in manufacturing management functions specializing in manufacturing processes and associated quality requirements of medicines, medical devices, nutraceuticals and cosmetics in a wide range of pharmaceutical dosage forms.

Since 2018 at Tilray, in the role of Qualified Person, André participated in the establishment of the company in Portugal, implementation of the pharmaceutical quality system and obtention of the GMP certifications, and currently ensures the release of cannabis products to patients around the world.

Tiago Santos

Tiago Santos

Co-Founder of Muvu Technologies

Tiago Peralta Santos is the Co-founder and CEO of Muvu Technologies. Tiago holds a Master’s in Electrical and Computer Engineering at the NOVA University of Lisbon, where he was a researcher at UNINOVA-CTS, a leading research center in AI and IoT.  ​

In 2015, Tiago founded Muvu Technologies to transform the industrial sector with cutting-edge technologies to improve productivity and reduce waste.

Tiago is also the Head of Product of the RAILES platform, a Smart MES (Manufacturing Execution System) that helps manufacturers digitize processes in the industry through real-time monitoring of production systems. Tiago is on a mission to bring all Industries to the 4.0 era.

Ruty Spier

Ruty Spier

Lead Auditor and Certifier of Control Union Certifications

Ruty Spier was involved in the development of the Israeli Standards for Medical Cannabis (IMC-G.A. P) and the global Standards for Medical Cannabis CUMCS-G.A.P, CUMCS EQUIVALENCY IMC-G.A.P.

She is the Lead auditor of CUMCS-G.A.P and Certifier of CUMCS EQUIVALENCY IMC-G.A.P

Ruty is involved in building seminars for medical cannabis for growers, Internal auditors, and Control-Union auditors. She’s also a lecturer at international conferences for medical cannabis, and a practical biology expert of fruits and vegetables with expertise in testing and standardization.

Ruty Spier

Ana Margarida de Jesus

Subintendent of the Public Security Police

Ana Margarida de Jesus, Subintendent of the Polícia de Segurança Pública, graduated in Police Sciences, post-graduated in Legal Medical Sciences and is attending a Master’s Degree course in Police Sciences, in the specialization of Security Management.​

Since 2003 she has headed various operational and administrative sub-units of the Public Security Police structure, namely Barreiro Police Station, Guimarães Criminal Investigation Station, Braga Police Division Command, where she organized and commanded major sporting and entertainment events.​

Working in the Department of Private Security since 2017, currently and since 2019 heads the Audit and Inspection Division of this department, the entity that certifies cannabis cultivation and production facilities.​

With participation in conferences underlying the theme of private security, she is also a trainer in this area in various police courses.​

Miguel-Fagundes

Adam Kavalier

Chief Scientific Officer (CSO) at Holistic Industries

Adam Kavalier, Chief Scientific Officer (CSO) at Holistic Industries, started his career in academic research and has been applying science to manufacturing and operations over the last 10 years, creating and building businesses in the food and Cannabis industries.

As CSO of Holistic Industries, a US-based multi-state vertically integrated Cannabis operator, Adam has built and scaled the manufacturing department from a single state into nine markets over six years. Adam also leads the science program, which is responsible for all product development and clinical trial research at Holistic Industries.

Prior to his work in the Cannabis industry, Adam conducted over 10 years of academic research in biochemistry and pharmacology. While in graduate school Adam also started and scaled a food science company which was recognized on National Public Radio, the Smithsonian and Nature Magazine.

Adam obtained his PhD from the City University of New York and New York Botanical Garden and conducted his post-doc research at Cornell Medical College. Adam’s academic work resulted in 10 peer-reviewed publications and two patents spanning research in mass spectrometry, medicinal plants, cancer pharmacology and drug discovery.

Ana Cristina Carrola

Member of the Board at Portuguese Environment Agency

Ana Cristina Carrola has a degree in Chemical Engineering from Higher Technical Institute of Lisbon in the area of Processes and Industry branch and a Post-Graduation in Water Quality and Pollution Control from the Civil Engineering Department of the Science and Technology Faculty of the University of Coimbra.

She develops and monitors issues in the environmental area since 1994, when she started public service functions at the Water Institute.

At APA she is responsible for the technical areas of Waste, Environmental Licensing, Environmental Reference Laboratory and its regional network and circular economy.

Joao Taborda da Gama

João Taborda da Gama

Partner of Gama Glória

João Taborda Gama is a founding partner of Gama Glória, a law firm based in Lisbon, a senior advisor of the Albright Stonebridge Group, in Washington DC, and he teaches at the Catholic University in Portugal. João is a member of the Scientific Committee of the Future Forum of the Gulbenkian Foundation and sits on the Business Ethics Committee of the Portuguese Pharma Association.

João advises governments, patients, NGOs and global companies on the regulation, use, production and trade of controlled substances in medical, religious, spiritual and recreational contexts. João has successfully advised global companies obtaining licenses to cultivate  and produce GACP/GMP medical cannabis, as well as securing a marketing authorization for the first registered medical cannabis product in Portugal. He advises on all aspects of the cannabis supply chain, including on international trade and transit, business combinations and taxation, and the CBD / Hemp market. João is a counsel companies doing research and using psychedelics to treat mental illness.

João has served as a political advisor to the President of Portugal and was a member of the Portuguese Government.

He published “The Regulation of Medical Cannabis in Portugal” (Brazil, 2019) and “Regulate and Protect: towards a new drug policy” (Lisbon, 2022).

Jonathan Haehn

Jonathan Haehn 

Co-Founder and CEO of Cannaflos

Jonathan Haehn is a graduated German engineer and co-founder and CEO of Cannaflos, a licensed GMP and GDP pharmaceutical company in Germany with strong focus on the finished product development for cannabinoid-based medicine always searching for innovative ways using digital tools to enhance the quality of life of patients.

In charge of business development and supply, Jonathan’s role is to achieve regulatory and qualitative requirements for cultivation and the subsequent processing steps for the production of medicinal cannabis products. Through the last 4 years of consulting, visiting and auditing GACP cultivation and GMP facilities in Israel, Colombia, Canada, Spain and Portugal Jonathan became an expert for medicinal cannabis in the field of pharmaceutical compliance, processing techniques, breeding, process validation, and sure quality assurance of all these processes.

With their consulting brand CANsulting, Jonathan and his team offer their expertise in regulatory compliance, market access strategies and product releases on the German market to cultivators and processors worldwide.

Jonathan is the driving force behind Cannaflos Genetics, a cannabis genetic and IP focused developing and licensing department of Cannaflos, that offers licensing of CPVO registered strains and customized strain development including preclinical studies.

As a highly motivated leader and team player he loves to create the situation of flow in teams leading to high performing individuals and amazing group dynamics.

pt_PTPortuguese